NCT05221567 is a NA clinical trial of Psychotherapy in Chronic Depression, sponsored by Modum Bad.

Who is sponsoring NCT05221567?

NCT05221567 is sponsored by Modum Bad.

What drugs are being tested in NCT05221567?

Interventions in NCT05221567: Psychotherapy.

What condition does NCT05221567 study?

NCT05221567 studies Chronic Depression, Persistent Depressive Disorder, Recurrent Major Depression.

Is NCT05221567 still recruiting?

NCT05221567 is currently completed. Last updated 3 February 2022.

Last reviewed 2022-02-03 · How we verify

NCT05221567

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intensive Psychotherapy for Chronic Depression

Completed NA Last updated 3 February 2022

What this trial tests

NA trial testing Psychotherapy in Chronic Depression in 280 participants. Completed in 31 December 2017.

Timeline

1 January 2012

Primary endpoint
31 December 2017

31 December 2017

Quick facts

Lead sponsor	Modum Bad
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	280
Start date	1 January 2012
Primary completion	31 December 2017
Estimated completion	31 December 2017

Drugs / interventions tested

Psychotherapy

Conditions studied

Chronic Depression — all drugs for Chronic Depression →
Persistent Depressive Disorder — all drugs for Persistent Depressive Disorder →
Recurrent Major Depression — all drugs for Recurrent Major Depression →

Sponsor

Modum Bad

Who can join

Adults 18 to 70, any sex, with Chronic Depression or Persistent Depressive Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study evaluates whether Intensive psychotherapy show superior effect on chronic depression over TAU

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effectiveness of an Intensive Inpatient Psychotherapy Program for Chronic Depression: A naturalistic comparison with wait list.
Eielsen M, Ulvenes PG, Røssberg JI, Høstmælingen A, et al · · 2022 · cited 5× · PMID 36451114 · DOI 10.1186/s12888-022-04381-5

Verify or expand the search:

Other trials of Psychotherapy

Trials testing the same drug.

NCT06827054 — Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids · Phase 2 · not yet recruiting
NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07250893 — Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression · NA · recruiting
NCT06353282 — MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents · Phase 2 · withdrawn

Other recruiting trials for Chronic Depression

Currently open trials in the same condition.

NCT05833087 — Schema Therapy for Patients With Chronic Treatment Resistant Depression · NA · recruiting

Other Modum Bad trials

Trials by the same sponsor.

NCT07432646 — "Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Tr · completed
NCT04444713 — Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols? · unknown
NCT04444115 — Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic · unknown
NCT04365881 — Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology · completed
NCT05993468 — A Pilot Study of a Trauma-Sensitive Mindfulness and Compassion Intervention · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05221567 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Modum Bad
Last refreshed: 3 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05221567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing